0001213900-18-013226.txt : 20180928 0001213900-18-013226.hdr.sgml : 20180928 20180928170703 ACCESSION NUMBER: 0001213900-18-013226 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180927 FILED AS OF DATE: 20180928 DATE AS OF CHANGE: 20180928 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pearson Mark E. CENTRAL INDEX KEY: 0001486558 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14778 FILM NUMBER: 181094865 MAIL ADDRESS: STREET 1: 3031 TISCH WAY STREET 2: SUITE 505 CITY: SAN JOSE STATE: CA ZIP: 95128 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SOLIGENIX, INC. CENTRAL INDEX KEY: 0000812796 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 411505029 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE B-10 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-538-8200 MAIL ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE B-10 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: DOR BIOPHARMA INC DATE OF NAME CHANGE: 20020329 FORMER COMPANY: FORMER CONFORMED NAME: ENDOREX CORP DATE OF NAME CHANGE: 19960916 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19920703 4 1 ownership.xml X0306 4 2018-09-27 0 0000812796 SOLIGENIX, INC. SNGX 0001486558 Pearson Mark E. 29 EMMONS DRIVE, SUITE B-10 PRINCETON NJ 08540 1 0 1 0 Stock Option (Right to Buy) 1.67 2018-09-27 4 A 0 17964 0 A 2028-09-26 Common Stock 17964 17964 D The stock option vests ratably on each of December 27, 2018, March 27, 2019, June 27, 2019 and September 27, 2019. /s/ Mark E. Pearson 2018-09-28